Aasta vahetumiseni on jäänud veel mõned nädalad ning paljuoodatud aastalõpu ralli ootus on vahetunud lootusega, et ehk näeme turgudel kosumist siis vähemalt jõulude eel ja järel, kui pessimistid on puhkusel ja investorid kulutavad boonuseid ning positsioneerivad oma portfelle maksimaalseteks maksusoodustusteks. Aga siiani on Euroopa uudised levitamas hirmu, et siit saab alguse sügavam globaalne majanduslik jahtumine ja vaadates eilset müügisurvet tooraineturgudel, siis pole väga imestada, miks ka aktsiaturgudel on ostjad loobunud üritamast vastuvoolu ujuda.
Täna on tulemas üsna korralikult makrot – potentsiaalne võimalus pöörata veidi rohkem tähelepanu sellele, kuidas tegelikult läheb majanduses. Hommikul avaldatud HSBC töötleva tööstuse PMI indeks jäi detsembris jätkuvalt alla 50 punkti, kuid võrreldes novembri 47,7 punkti tasemega näidati siiski väikest paranemist tasemele 49 punkti. Ehk antud sektori aktiivsus on alanemas, kuid seda aeglasemas tempos võrreldes novembriga. 
Kell 11.00 kuuleme millised on siiani detsembris olnud trendid eurotsooni töötlevas tööstuses. Kui näeme veidikenegi paranemist, siis ma usun, et see võib olla piisavaks katalüsaatoriks positiivsemale sentimendile turgudel.
Kell 11.30 raporteeritakse Suurbritannia novembri jaemüügi muutus, kell 12.00 eurotsooni novembri lõplik tarbijahinnaindeksi muutus, kell 15.30 USA möödunud nädala töötuabiraha taotluste arv, Empire State töötleva tööstuse detsembri küsitlus, 16.15 USA novembri tööstustoodang ja kell 17.00 Philadelphia Fedi detsembri küsitlus.
USA indeksite futuurid on kauplemas 0,1% jagu miinuspoolel ning Euroopa avanemas üsna nulli lähedal.
Järelturul teatas Lam Research, et ostab Novelluse.
Novellus trades over 20% higher announcement to be acquired by Lam Research
Novellus to be purchased by Lam Research (LRCX); Based on the closing price of LRCX's stock on Dec 14, 2011, the transaction values NVLS at a price of $44.42/common share
BioSante Pharmaceuticals, Inc. (BPAX) müüdi järelturul 76% madalamale.
LibiGel does not achieve primary endpoints
Novellus trades over 20% higher announcement to be acquired by Lam Research
Novellus to be purchased by Lam Research (LRCX); Based on the closing price of LRCX's stock on Dec 14, 2011, the transaction values NVLS at a price of $44.42/common share
BioSante Pharmaceuticals, Inc. (BPAX) müüdi järelturul 76% madalamale.
LibiGel does not achieve primary endpoints
Oma hiljuti lõppenud kvartali tulemused raporteerib enne USA turgude avanemist FedEx, kes on viimastes kommentaarides jäänud globaalse majanduse suhtes võrdlemisi positiivseks ja kindlasti soovitakse täna kuulda, et seisukoht pole muutnud. Peale turgu aga avalikustab oma majandustulemused Research in Motion.
Prantsusmaa PMI numbrid oodatust paremad ning ühtlasi kõrgemad võrreldes eelneva kuuga
French Manufacturing PMI (Dec P) M/M 48.7 vs. Exp. 47.0 (Prev. 47.3)
French Services PMI (Dec P) M/M 50.2 vs. Exp. 49.0 (Prev. 49.6)
French Manufacturing PMI (Dec P) M/M 48.7 vs. Exp. 47.0 (Prev. 47.3)
French Services PMI (Dec P) M/M 50.2 vs. Exp. 49.0 (Prev. 49.6)
Morgan Stanley on pannud kokku nimekirja 50 ettevõttest, mida täna osta ning kuni 2015. aastani hoida. Antud pikaajaliste ideede puhul on oluliseks argumendiks ärimudeli kvaliteet ja jätkusuutlikkus, mis võiks vastu pidada ka keerulisemates majanduslikes oludes (ettevõte suudab säilitada konkurentsivõime, hinnastamise võime, kuluefektiivsuse ja äritegevuse kasvu).
Saksamaa PMId arvatust paremad ning ilmselt saavad seda olema ka eurotsooni üldised näitajad
German Manufacturing PMI (Dec A) M/M 48.1 vs. Exp. 47.5 (Prev. 47.9)
German Services PMI (Dec A) M/M 52.7 vs. Exp. 50.0 (Prev. 50.3)
German Manufacturing PMI (Dec A) M/M 48.1 vs. Exp. 47.5 (Prev. 47.9)
German Services PMI (Dec A) M/M 52.7 vs. Exp. 50.0 (Prev. 50.3)
Eurotsooni töötleva tööstuse PMI marginaalselt parem, kuigi tase jääb endiselt murettekitavaks
Eurozone Manufacturing PMI (Dec A) M/M 46.9 vs. Exp. 46.0 (Prev. 46.4)
Eurozone Services PMI (Dec A) M/M 48.3 vs. Exp. 47.0 (Prev. 47.5)
Eurozone Composite PMI (Dec A) M/M 47.9 vs. Exp. 46.5 (Prev. 47.0)
Eurozone Manufacturing PMI (Dec A) M/M 46.9 vs. Exp. 46.0 (Prev. 46.4)
Eurozone Services PMI (Dec A) M/M 48.3 vs. Exp. 47.0 (Prev. 47.5)
Eurozone Composite PMI (Dec A) M/M 47.9 vs. Exp. 46.5 (Prev. 47.0)
UK Retail Sales (Nov) M/M -0.4% vs. Exp. -0.3% (Prev. 0.6%, Rev. 1.0%)
UK Retail Sales (Nov) Y/Y 0.7% vs. Exp. 0.4% (Prev. 0.9%, Rev. 1.1%)
UK Retail Sales (Nov) Y/Y 0.7% vs. Exp. 0.4% (Prev. 0.9%, Rev. 1.1%)
Vaatamata oodatust paremale makrole pole euro suutnud dollari vastu om hommikust tõusu hoida, kui praeguseks kaupleb vahetuskurss -0,15% madalamal ning lähenemas uuesti eilsete põhjade juurde
Spain sells EUR6.03 bln vs €2.5-3.5 bln in 2016, 2020 AND 2021 bonds
•Sells EUR2.451bln in 3.15% 2016 Bonos; avg yield 4.023% vs 5.276% prior; Bid-to-cover: 1.99x vs 2.83x prior; Max Yield 4.058% vs 5.280% prior
•Sells EUR2.177bln in 4.0% 2020 Bonos; avg yield 5.239% v 5.006% prior; Bid-to-cover: 1.52x vs 2.01x prior; Max Yield 5.239% vs 5.05% prior
•Sells EUR1.400bln in 5.5% 2021 Bonos; avg yield 5.545% v 5.433% prior; Bid-to-cover: 2.16x vs 1.76x prior; Max Yield 5.564% vs 5.453% prior
•Sells EUR2.451bln in 3.15% 2016 Bonos; avg yield 4.023% vs 5.276% prior; Bid-to-cover: 1.99x vs 2.83x prior; Max Yield 4.058% vs 5.280% prior
•Sells EUR2.177bln in 4.0% 2020 Bonos; avg yield 5.239% v 5.006% prior; Bid-to-cover: 1.52x vs 2.01x prior; Max Yield 5.239% vs 5.05% prior
•Sells EUR1.400bln in 5.5% 2021 Bonos; avg yield 5.545% v 5.433% prior; Bid-to-cover: 2.16x vs 1.76x prior; Max Yield 5.564% vs 5.453% prior
SonoSite (SONO) to be acquired by Fujifilm for $54 per share
Co announces that FUJIFILM Holdings has entered into a definitive agreement with co, to acquire SONO for ~$995 mln (The transaction was unanimously approved by the Boards of Directors of both companies.). Fujifilm, through a U.S. subsidiary, will make an all-cash tender offer to purchase all outstanding shares of SONO common stock for $54 per share in cash. The purchase price represents a premium of 50.0% over co's average closing stock price over the three months ended December 14, 2011.
Co announces that FUJIFILM Holdings has entered into a definitive agreement with co, to acquire SONO for ~$995 mln (The transaction was unanimously approved by the Boards of Directors of both companies.). Fujifilm, through a U.S. subsidiary, will make an all-cash tender offer to purchase all outstanding shares of SONO common stock for $54 per share in cash. The purchase price represents a premium of 50.0% over co's average closing stock price over the three months ended December 14, 2011.
Tata Motors Ltd. (TTM) said Thursday its global sales in November rose 35% from a year earlier to 108,028 vehicles.
India's biggest auto maker by revenue said its U.K.-based Jaguar Land Rover unit sold 29,183 vehicles in November, higher by 27% from a year earlier.
Sales of Jaguar cars fell 5% to 5,315 units while those of Land Rover sport-utility vehicles gained 38% to 23,868 units.
The company said it sold 49,724 trucks and buses globally in November, up 24% from a year earlier.
India's biggest auto maker by revenue said its U.K.-based Jaguar Land Rover unit sold 29,183 vehicles in November, higher by 27% from a year earlier.
Sales of Jaguar cars fell 5% to 5,315 units while those of Land Rover sport-utility vehicles gained 38% to 23,868 units.
The company said it sold 49,724 trucks and buses globally in November, up 24% from a year earlier.
Eilne uudis aga neg turu taustal jäi kahvatuks:
Broadcom (BRCM): Raising Q4 estimates above consensus following analyst day - Benchmark
Benchmark notes, BRCM hosted its annual analyst day, during which management highlighted the company's long-term vision as well as provided upwardly revised 4Q11 guidance. The firm is raising their 4Q11 revenue/EPS estimates from $1.76 billion /$0.61 to $1.8 billion/$0.65. vs $1.79 bln and $0.63 Capital IQ consensus. The firm is now assuming 6% revenue growth for FY12 compared to their chip industry sales growth forecast of flat to up 5%.
Broadcom (BRCM): Raising Q4 estimates above consensus following analyst day - Benchmark
Benchmark notes, BRCM hosted its annual analyst day, during which management highlighted the company's long-term vision as well as provided upwardly revised 4Q11 guidance. The firm is raising their 4Q11 revenue/EPS estimates from $1.76 billion /$0.61 to $1.8 billion/$0.65. vs $1.79 bln and $0.63 Capital IQ consensus. The firm is now assuming 6% revenue growth for FY12 compared to their chip industry sales growth forecast of flat to up 5%.
Skyworks upgraded to Buy from Hold at Deutsche Bank
FedEx prelim $1.57 vs $1.53 Capital IQ Consensus Estimate; revs $10.59 bln vs $10.61 bln Capital IQ Consensus Estimate; reaffirms FY12 EPS
DECK dg on kuri, aga keegi juba tahab mõlemad aktsiad iga hinna ees ära shortida.
Sterne on DECK-i andunud fännboi olnud, läbi paksu ja vedela läinud, isegi ajuvaba CROX-i hoiatuse peale DECK selloffi defendis siin sügisel. Õigus tal oligi.
See saab täna tappa.
See saab täna tappa.
Apple named a long Research Tactical Idea at Morgan Stanley
Sterne hinnasiht ise on juba üsna kuri - $ 72, mis on ka street low. Siiani oli madalaim $ 106, kui mu andmed õiged on.
Gapping up
In reaction to strong earnings/guidance: FDX +3%, MTL +2.7% (light volume), AET +0.3% (ticking higher).
M&A related: SONO +26.8% (SonoSite to be acquired by Fujifilm for $54 per share), NVLS +24.1% (Novellus to be purchased by Lam Research (LRCX); Based on the closing price of LRCX's stock on Dec 14, 2011, the transaction values NVLS at a price of $44.42/common share), WLT +2.7% (ticking higher following UK story suggesting potential M&A).
Financial related names showing strength: RBS +3.4%, C +2.4%, BAC +2.3%, MS +2.3%, CS +2.1%, UBS +1.1%, BCS +1%, .
Select metals/mining stocks trading higher: SVM +3.4%, MT +2.4%, ABX +1.3%, SLW +1.3%, GLD +1.3%, SLV +0.8%, .
Other news: CEDC +10.1% (ticking higher, checking for any catalyst), TER +4.8% (still checking), VRTX +1.2% (reports FDA has accepted the NDA for KALYDECOTM and granted the co's request for six-month Priority Review), TRIPV +1% (will replace Tellabs in the S&P 500 index), ARIA +1.2% (Ariad Pharm files mixed securities shelf offering and announces proposed public offering of common stock).
Analyst comments: AIXG +5.8% (upgraded to Neutral from Reduce at WestLB ), ELN +2.4% (upgraded to Buy from Hold at Deutsche Bank), BRCM +1.9% (upgraded to Outperform from Market Perform at Wells Fargo), IPG +1.1% (initiated with an Overweight at Barclays), AAPL +0.8% (named a long Research Tactical Idea at Morgan Stanley), CSCO +0.7% (initiated with a Buy at Nomura).
In reaction to strong earnings/guidance: FDX +3%, MTL +2.7% (light volume), AET +0.3% (ticking higher).
M&A related: SONO +26.8% (SonoSite to be acquired by Fujifilm for $54 per share), NVLS +24.1% (Novellus to be purchased by Lam Research (LRCX); Based on the closing price of LRCX's stock on Dec 14, 2011, the transaction values NVLS at a price of $44.42/common share), WLT +2.7% (ticking higher following UK story suggesting potential M&A).
Financial related names showing strength: RBS +3.4%, C +2.4%, BAC +2.3%, MS +2.3%, CS +2.1%, UBS +1.1%, BCS +1%, .
Select metals/mining stocks trading higher: SVM +3.4%, MT +2.4%, ABX +1.3%, SLW +1.3%, GLD +1.3%, SLV +0.8%, .
Other news: CEDC +10.1% (ticking higher, checking for any catalyst), TER +4.8% (still checking), VRTX +1.2% (reports FDA has accepted the NDA for KALYDECOTM and granted the co's request for six-month Priority Review), TRIPV +1% (will replace Tellabs in the S&P 500 index), ARIA +1.2% (Ariad Pharm files mixed securities shelf offering and announces proposed public offering of common stock).
Analyst comments: AIXG +5.8% (upgraded to Neutral from Reduce at WestLB ), ELN +2.4% (upgraded to Buy from Hold at Deutsche Bank), BRCM +1.9% (upgraded to Outperform from Market Perform at Wells Fargo), IPG +1.1% (initiated with an Overweight at Barclays), AAPL +0.8% (named a long Research Tactical Idea at Morgan Stanley), CSCO +0.7% (initiated with a Buy at Nomura).